Composition containing orlistat and alginic acid or derivatives of alginic acid and application of composition

A technology of orlistat and alginic acid, which is applied in the field of medicine, can solve the problem of low content of active ingredients, achieve the effect of improving treatment outcomes and reducing treatment costs

Active Publication Date: 2020-05-08
中山万远新药研发有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, since plant extracts are often low in active ingredients, relatively high doses are required to produce clinically meaningful therapeutic effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition containing orlistat and alginic acid or derivatives of alginic acid and application of composition
  • Composition containing orlistat and alginic acid or derivatives of alginic acid and application of composition
  • Composition containing orlistat and alginic acid or derivatives of alginic acid and application of composition

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0023] The preparation of preparation example 1 green plum flower extract

[0024] The green plum flower used in the present invention is the Da Yeqing variety in Xiaoshan Daqingmei, which is collected from Meilin, Huaxing Town, Xiaoshan District, Hangzhou City, Zhejiang Province. After picking, it is vacuum-dried in time (with a water content below 10%), and stored at room temperature in the dark.

[0025] The green plum flower raw material is dried, crushed with a universal Chinese medicine pulverizer, and passed through a 40-mesh sieve, and 1 kg is taken, and ethanol (30%, v / v) is added to make the material-liquid ratio=1:10, w / v, at 60-70°C Reflux extraction for 2 hours, extract twice under the same conditions, combine the two extracts, concentrate under reduced pressure and freeze-dry to obtain a brown powder sample, then vacuum-sealed and packaged, the radiation source is 60Co-γ, and the radiation dose is 6kGy , sterilized by irradiation and stored in a refrigerator at 4...

preparation example 2

[0026] Preparation Example 2 Preparation of medium and low molecular weight alginic acid or its derivatives from commercially available high molecular weight alginic acid or its derivatives

[0027] The present invention firstly purchases high molecular weight alginic acid or its derivatives whose molecular weight is shown in Table 1 through GPC method through commercial channels, and uses the lowest molecular weight high molecular weight alginic acid or its derivatives in Table 1 as raw material through microwave-assisted Alginic acid or its derivatives with medium molecular weight were prepared by hydrogen peroxide degradation method.

[0028] Table 1 Commercially available high molecular weight alginic acid or its derivatives used in the present invention

[0029]

[0030]Add 1.5g of alginic acid or its derivatives to 100mL of deionized water, stir and mix well, let it stand overnight, add 30% hydrogen peroxide solution dropwise to the resulting solution, so that the fin...

preparation example 3

[0033] Preparation Example 3 Composition of Orlistat and Alginic Acid or Its Derivatives

[0034] Preparation Example 3 provides 7 groups of compositions containing orlistat, alginic acid or derivatives thereof, and the specific qualities of the compositions are shown in Table 2. Wherein orlistat (denoted as ORL) and the mass ratio of alginic acid or derivatives thereof shown in table 1, table 2 is the composition that α forms, and is denoted as composition A; PF and orlistat and alginic acid or its derivatives at a mass ratio of 1:0.5, which is referred to as composition B.

[0035] Table 3 Composition formula of orlistat and alginic acid or derivatives thereof

[0036]

[0037]

[0038]

[0039]

[0040]

[0041]

[0042]

[0043]

[0044] Note: The mass ratio is: the mass ratio of orlistat to alginic acid and its derivatives, and the components are connected with "-" to indicate the mixture, the same below.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Weight average molecular weightaaaaaaaaaa
Weight average molecular weightaaaaaaaaaa
Weight average molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of medicines, and particularly relates to a composition containing orlistat and alginic acid or derivatives of alginic acid. The composition comprises orlistat, alginic acid or derivatives of alginic acid. In the composition, the mass ratio of the orlistat to alginic acid or derivatives of alginic acid is 1:(0.01-100), and the weight average molecular weight of the alginic acid or derivatives of alginic acid is 1.36 kDa-598.56 kDa. In the composition, the orlistat and alginic acid or derivatives of alginic acid have synergistic inhibitory effect oninhibition of green plum-blossom extracts on viridans streptococcus, staphylococcus hominis, haemophilus influenzae and enterococcus faecalis, and have synergistic anti-tumor cell proliferation effecton inhibition of the green plum-blossom extracts on proliferation of prostate cancer, ovarian cancer and pancreatic cancer cells.

Description

technical field [0001] The invention belongs to the technical field of medicine, and specifically relates to a composition containing orlistat and alginic acid or derivatives thereof and its application. Background technique [0002] Nosocomial infection is an important issue affecting the quality of hospital care. With the continuous development and progress of modern medical technology, antibacterial drugs are widely used, and the drug-resistant strains of clinical pathogens are increasing. In addition, chemotherapy and radiotherapy are widely used in the treatment of inpatients with cancer, and the immune function of the patients is reduced. The use of endoscopes and various catheters increases the chance of pathogenic microorganisms invading the body, and finally leads to the number of nosocomial infections in cancer patients. increasing trend. Therefore, the clinical application of anti-tumor and anti-bacterial infection drugs can not only improve the treatment outcom...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/734A61K31/365A61K36/185A61P35/00A61P31/04
CPCA61K31/734A61K31/365A61K36/185A61P35/00A61P31/04A61K2236/333A61K2236/39A61K2236/51A61K2300/00Y02A50/30
Inventor向飞杜志博王鹤然李玲钟明丽彭韪
Owner中山万远新药研发有限公司